» Articles » PMID: 279930

Amyloid Fibril Protein Related to Prealbumin in Familial Amyloidotic Polyneuropathy

Overview
Specialty Science
Date 1978 Sep 1
PMID 279930
Citations 106
Authors
Affiliations
Soon will be listed here.
Abstract

Amyloid fibrils were concentrated from the kidney, thyroid, and peripheral nerve of six patients with familial amyloidotic polyneuropathy (FAP). The fibril concentrates were solubilized in 6 M guanidine.HCl and fractionated on Sephadex G-100 columns. The elution profile of all FAP amyloid fibril concentrates revealed a protein of apparent Mr of 14,000, designated the FAP protein, that was absent from normal human tissues treated by the same procedure and from fibrils of a primary amyloidosis liver. Antisera against whole denatured fibril concentrates prepared in rabbits reacted with the FAP protein and a component in normal human serum corresponding to prealbumin. It was further established that the FAP protein shared common antigenic determinants with human prealbumin by its reaction of identity with normal prealbumin using commercial antisera against human prealbumin. Amyloid AL or AA proteins could not be identified in FAP fibrils by sensitive immunochemical assay methods. These results suggest that the FAP protein is a unique and significant component of the FAP amyloid fibrils and that it is closely related to the 13,745 Mr prealbumin subunit.

Citing Articles

Diagnostic and therapeutic challenges in rapidly progressing cardiac amyloidosis: a literature review based on case report.

Senobari N, Nazari R, Ebrahimi P, Soleimani H, Taheri M, Hosseini K Int J Emerg Med. 2024; 17(1):159.

PMID: 39433996 PMC: 11495085. DOI: 10.1186/s12245-024-00750-x.


Structural Basis for Monoclonal Antibody Therapy for Transthyretin Amyloidosis.

Chakrabartty A Pharmaceuticals (Basel). 2024; 17(9).

PMID: 39338387 PMC: 11435174. DOI: 10.3390/ph17091225.


Conformational Dynamics of an Amyloidogenic Intermediate of Transthyretin: Implications for Structural Remodeling and Amyloid Formation.

Leach B, Ferguson J, Morgan G, Sun X, Kroon G, Oyen D J Mol Biol. 2024; 436(16):168673.

PMID: 38909653 PMC: 11410348. DOI: 10.1016/j.jmb.2024.168673.


Inhibitors of Transthyretin Amyloidosis: How to Rank Drug Candidates Using X-ray Crystallography Data.

Leite J, Costa-Rodrigues D, Gales L Molecules. 2024; 29(4).

PMID: 38398647 PMC: 10893244. DOI: 10.3390/molecules29040895.


Thyroxine metabolite-derived 3-iodothyronamine (T1AM) and synthetic analogs as efficient suppressors of transthyretin amyloidosis.

Kim B, Ko Y, Si J, Na J, Ortore G, Chiellini G Comput Struct Biotechnol J. 2023; 21:4717-4728.

PMID: 37822560 PMC: 10562617. DOI: 10.1016/j.csbj.2023.09.028.


References
1.
Andrade C . A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain. 1952; 75(3):408-27. DOI: 10.1093/brain/75.3.408. View

2.
Shapiro A, Vinuela E, Maizel Jr J . Molecular weight estimation of polypeptide chains by electrophoresis in SDS-polyacrylamide gels. Biochem Biophys Res Commun. 1967; 28(5):815-20. DOI: 10.1016/0006-291x(67)90391-9. View

3.
OPPENHEIMER J . Role of plasma proteins in the binding, distribution and metabolism of the thyroid hormones. N Engl J Med. 1968; 278(21):1153-62. DOI: 10.1056/NEJM196805232782107. View

4.
Glenner G, Page D . Amyloid, amyloidosis, and amyloidogenesis. Int Rev Exp Pathol. 1976; 15:1-92. View

5.
Blake C, Geisow M, Swan I, Rerat C, RERAT B . Strjcture of human plasma prealbumin at 2-5 A resolution. A preliminary report on the polypeptide chain conformation, quaternary structure and thyroxine binding. J Mol Biol. 1974; 88(1):1-12. DOI: 10.1016/0022-2836(74)90291-5. View